PharmaShots Weekly Snapshot (September 30'October 04, 2019)
Published: Oct 03, 2019 | Tags: Arbutus, Discontinue, P-Ia/Ib, Clinical Study, AB-506, Chronic Hepatitis B
Published: Oct 03, 2019 | Tags: Janssen, Niraparib, Receives, US, FDA, Breakthrough Therapy Designation, Metastatic Castration-Resistant Prostate Cancer
3. Silver Cloud Health Partners with Microsoft to Deploy AI for Enhancing its Digital Mental Healthcare
Published: Oct 02, 2019 | Tags: Silver Cloud Health, Partners, Microsoft, Deploy, AI, Digital Mental Healthcare
Published: Oct 04, 2019 | Tags: AstraZeneca, Fasenra Pen, Pre-Filled Auto-Injector, Receives, US, FDA, Approval, Severe Eosinophilic Asthma
5.Gilead's Descovy Receives the US FDA's Approval for HIV Pre-Exposure Prophylaxis
Published: Oct 03, 2019 | Tags: Gilead, Descovy, Receives, US, FDA, Approval, HIV Pre-Exposure Prophylaxis
Published: Oct 03, 2019 | Tags: Takeda, Signs, License Agreement, Goldfinch Bio, GFB-024, Rare and Metabolic Kidney Diseases
Published: Oct 01, 2019 | Tags: Novo Nordisk, Collaborates, Noom, Digital Health Solutions, Weight Management, Patients, Obesity
8. Eli Lilly Reports the Availability of Emgality (galcanezumab) to Prevent Migraine in Canada
Published: Oct 02, 2019 | Tags: Eli Lilly, Reports, Availability, Emgality, galcanezumab, Prevent, Migraine, Canada
Published: Oct 02, 2019 | Tags: Merck, Keytruda, Receives, NMPA, Approval, Monotherapy, 1L, Advanced Non-Small Cell Lung Cancer, PD-L1 Tumor Expression, China
Published: Oct 02, 2019 | Tags: Eli Lilly, Reports, Results, Taltz, ixekizumab, Head-to-Head, P-IV, IXORA-R, Study, Moderate to Severe Plaque Psoriasis
11. Philips Collaborates with Air Ambulance Kent Surrey Sussex to Provide Emergency Services in the UK
Published: Oct 03, 2019 | Tags: Philips, Collaborates, Air Ambulance Kent Surrey Sussex, Provide, Emergency Services, UK
12. Biocon and Mylan Launch Semglee (biosimilar, Insulin Glargine) in Australia
Published: Oct 03, 2019 | Tags: Biocon, Mylan, Launch, Semglee, biosimilar, Insulin Glargine, Australia
Published: Oct 01, 2019 | Tags: Novartis, Signs, Multiyear Agreement, Microsoft, Reimagining Medicine, Launch, Novartis, AI Innovation Lab
14. Pfizer to Launch its Zirabev (biosimilar, bevacizumab) in the US by the year end 2019
Published: Sept 30, 2019 | Tags: Pfizer, Launch, Zirabev, Biosimliar, Bevacizumab, US, 2019
Published: Oct 01, 2019 | Tags: Eisai, Signs, Research, Option Agreement, Numab, Discover, Develop, Multi-Specific Antibody, Immunotherapies, Cancer
16. Taisho Signs an Exclusive License Agreement with Moberg Pharma to Develop and Commercialize MOB-015 in Japan
Published: Oct 01, 2019 | Tags: Taisho, Signs, Exclusive, License Agreement, Moberg Pharma, Develop, Commercialize, MOB-015, Japan
Published: Sept 30, 2019 | Tags: Roche, Reports, Result, Tecentriq, atezolizumab, P-III, IMvigor130 Study, Advanced Bladder Cancer
18.Janssen's Invokana (canagliflozin) Receives the US FDA's Approval for Patients with Type 2 Diabetes and Diabetic Kidney Disease
Published: Oct 01, 2019 | Tags: Janssen, Invokana, canagliflozin, Receives, US, FDA, Approval, Type 2 Diabetes, Diabetic Kidney Disease
19. AstraZeneca to Divest Worldwide Commercialization Rights of Losec (omeprazole) to Cheplapharm
Published: Oct 01, 2019 | Tags: AstraZeneca, Divest, Worldwide, Commercialization, Rights, Losec, omeprazole, Cheplapharm
Published: Sept 30, 2019 | Tags: SymBio, Signs, Worldwide, Exclusive, License Agreement, Chimerix, Develop, Commercialize, Brincidofovir
21. Celltrion Signs an Exclusive Co-Marketing Agreement with Juno in Australia
Published: Sept 30, 2019 | Tags: Celltrion, Co-Marketing Agreement, Juno, Australia
22. Vertex Collaborates with Ribometrix to Discover and Develop up to Three RNA Targeted Candidates
Published: Sept 30, 2019 | Tags: Vertex, Collaborates, Ribometrix, Discover, Develop, Three, RNA Targeted Candidates
Published: Sept 30, 2019 | Tags: Merck, Reports, Results, Recarbrio, imipenem, cilastatin, relebactam, P-III, RESTORE-IMI 2, HABP, VABP
24. GSK Reports Results of Nucala (mepolizumab) in REALITI-A Study for Severe Eosinophilic Asthma
Published: Sept 30, 2019 | Tags: GSK, Reports, Results, Nucala, mepolizumab, REALITI-A, Severe Eosinophilic Asthma
Published: Sept 30, 2019 | Tags: Roche, Rituxan, rituximab, Receives, US, FDA, Approval, Two, Rare Blood Vessel Disorders, Pediatric Patients
26.Sobi to Acquire Dova Pharmaceuticals for $915M
Published: Sept 30, 2019 | Tags: Sobi, Acquire, Dova Pharmaceuticals, $915M
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com